Hexarelin

Also known as: Examorelin

Growth HormonePHASE 2

Clinical Status

Investigational — clinical trials conducted.

Mechanism of Action

Activates ghrelin receptors causing potent GH release. Uniquely binds to CD36 receptors in cardiac tissue, providing cardioprotective effects independent of GH.

Dosing Defaults

Dose

100-200 mcg

Frequency

2-3x daily

Administration

Subcutaneous injection

Timing

Morning and before bed (fasted)

Food

fasted

Duration

4-8 weeks

Dose range: 100-300 mcg per dose

Take fasted for maximum GH response.

Side Effects

•Increased appetite
•Water retention
•Tingling/numbness
•Elevated cortisol and prolactin
•Flushing
•Receptor desensitization with continuous use

Contraindications & Warnings

⚠Active malignancy

•Not medical advice
•Desensitization occurs with continuous use — cycle off

Compare

Compare Hexarelin with another peptide side-by-side.

Calculate Dose

Use the reconstitution calculator to prepare your Hexarelin dose.

Open Calculator

Related Growth Hormone Peptides

Ipamorelin

PHASE 2

Growth Hormone

Selective GH secretagogue. Considered one of the safest GHRPs.

CJC-1295

PHASE 2

Growth Hormone

Synthetic GHRH analog that stimulates GH release from the pituitary.

CJC-1295 DAC

PHASE 2

Growth Hormone

Long-acting version of CJC-1295 with extended half-life via albumin binding.

Tesamorelin

FDA APPROVED

Growth Hormone

FDA-approved GHRH analog for visceral fat reduction in HIV lipodystrophy.

This information is for educational purposes only and is not medical advice. Dosing data is based on research literature and community reports. Always consult a qualified healthcare provider before using any peptide.